Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Study Shows Promise for Dupilumab in Treating Hand and Foot Dermatitis

May 5, 2023

A study published in the Journal of Allergy and Clinical Immunology: In Practice reports that Dupilumab holds promise for adults and adolescents with moderate to severe atopic hand and foot dermatits.

This comes 6 years after the FDA approved Dupixent® (dupilumab) for atopic dermatitis.